HARROW, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.38 USD | +27.46% |
|
+39.58% | +36.34% |
| 13/05 | Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours | MT |
| 13/05 | Harrow, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HARROW, INC. | Other Pharmaceuticals | +26.43% | +39.58% | +36.34% | -26.90% | +188.11% | 43Cr |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- HROW Stock
- Charts Harrow, Inc.
- Comparison Chart